Giulio Cossu, MD, University of Manchester, discusses barriers to gene therapy research and development.
Cell- and gene-therapy-focused ElevateBio has let go of 17% of staffers as part of the company’s second layoff round since ...
Out of the shadows, new CDMO Artis BioSolutions has decloaked on a mission to tackle the tricky production process for ...
MyChesCo on MSN19d
ChromaTan and Landmark Bio Receive NIIMBL Grant to Advance AAV Gene Therapy ManufacturingChromaTan Inc. and Landmark Bio PBLLC have been awarded a grant from the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) to support the ...
the focus of stakeholders has now shifted to optimizing the cell therapy manufacturing process. At present, over 260 industry and non-industry players are engaged in the cell therapy manufacturing ...
Landmark Bio acquired by Artis BioSolutions to expand manufacturing and commercialization of advanced therapies: Watertown, Massachusetts Thursday, April 3, 2025, 14:00 Hrs [IST] ...
MeiraGTx has one gene therapy in a potentially pivotal clinical ... over the course of nearly a decade developing its manufacturing process. Hologen’s technology will continue to have a role ...
Gene therapy, which promises a possible cure for rare diseases like sickle cell, is losing early investors to higher-reward ...
Artis BioSolutions, founded to streamline the discovery, development & production of genetic medicines, has launched and ...
A new study in the journal Human Gene Therapy indicates that DNA impurities derived from plasmid and host cell DNA are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback